UCB - Marktkapitalisierung





Marktkapitalisierung Veränderung Datum
Alcon AG USD 30.17B 6.88B 2026-08
Almirall EUR 2.76B 472.53M 2025-12
Amarin USD 290M 51M 2025-12
argenx SE USD 57.63B 13.25B 2026-06
AstraZeneca USD 178.16B 111.83B 2026-08
Bayer EUR 48.39B 834.21M 2026-08
Genmab DKK 126.96B 109.86B 2026-08
GlaxoSmithKline GBP 80.14B 3.66B 2026-06
GRIFOLS EUR 4.25B 1.16B 2026-08
Hikma Pharmaceutical USD 3.49B 1.14B 2026-08
Lakefront Biotherapeutics EUR 1.54B 180.56M 2026-08
Lonza CHF 39.68B 980.61M 2025-06
Merck EUR 62.37B 43.39B 2026-08
Novartis USD 240.59B 67.17B 2026-06
Orion EUR 10.15B 316M 2026-06
Recordati EUR 10.65B 209.88M 2026-08
Roche Holding CHF 270B 3.66B 2026-06
Sanofi EUR 91.15B 9.12B 2026-06
UCB EUR 46.41B 13.94B 2025-12
Unibail Rodamco EUR 14.55B 1.26B 2026-08